ࡱ> mpjkl[Zbjbj4ΐΐ2PP!!!!!!!!!" !#####$$$>@@@@@@$Cbdu!$$$$$d!!##ٸPPP$V!#!#>P$>PPf#-=5b!> D*0LJ!4$$P$$$$$dd7P$$$$$$$$$$$$$$$$P( x : " !3 548:>  B5E=VG=V E0@0:B5@8AB8:8 ?> ?@54<5BC 70:C?V2;V  021:2015: 33600000-6 $0@<0F52B8G=0 ?@>4C:FVO (V:0@AL:V 70A>18 . Omeprazole, Drotaverine, Metoclopramide, Ondansetron, Enoxaparin, Tranexamic acid, Furosemide, Dexamethasone, Ceftriaxone, Azithromycin, Ammonia, Amiodarone, Metamizole sodium, Amikacin, Acetylcysteine, Oxybuprocaine, Bupivacaine, Verapamil, Heparin, Aciclovir, Diclofenac Pantoprazole, Isosorbide dinitrate, Anti-D (rh) immunoglobulin, Acetylcysteine, Imipenem and cilastatin, Phytomenadione, Captopril, Lidocaine, Bupivacaine, Drotaverine, Oxytocin, Multienzymes (lipase, protease etc.), Paracetamol, Pentoxifylline, Clopidogrel, Prednisolone, Neostigmine, Budesonide, Oxymetazoline, Formoterol and budesonide, Comb drug, Tobramycin, Tropicamide, Enoxaparin, Cefazolin, Cefotaxime, Cyanocobalamin, Ciprofloxacin, Ondansetron, Ketorolac,Cetirizine, Barbiturates in combination with other drugs, Comb drug, Castor oil, Medicinal charcoal, Haloperidol, Albumin, Aciclovir, Levothyroxine sodium, Medicinal charcoal, Ibuprofen) 0?@>?>=>20=89 CG0A=8:>< B>20@ 70 <548:>  B5E=VG=8<8 2;0AB82>ABO<8 ?>28=5= 2V4?>2V40B8 =0ABC?=8< <548:>  B5E=VG=8< 28<>30<: 1. #G0A=8: 287=0G0T FV=8 =0 B>20@8, O:V 2V= ?@>?>=CT ?>AB028B8 70 >3>2>@><, 7 C@0EC20==O< CAVE A2>WE 28B@0B =0 4>AB02:C, AB@0EC20==O B>20@C, ?>40B:V2 V 71>@V2, I> A?;0GCNBLAO 01> <0NBL 1CB8 A?;0G5=V, CAVE V=H8E 28B@0B. 2. #G0A=8: ?>28=5= 70157?5GC20B8 =0;56=V C<>28 715@V30==O B0 B@0=A?>@BC20==O ;V:0@AL:8E 70A>1V2: =040B8 C A:;04V B5=45@=>W ?@>?>78FVW 4>:C<5=B8 =0 ?V4B25@465==O =0O2=>ABV 2 CG0A=8:0 2;0A=8E 01> >@5=4>20=8E A:;04AL:8E ?@8<VI5=L B0 B@0=A?>@BC 4;O 70157?5G5==O C<>2 715@V30==O "E>;>4>289 ;0=FN3". 3. #AV 70?@>?>=>20=V ;V:0@AL:V 70A>18 <0NBL 1CB8 =0;56=8< G8=>< 70@5TAB@>20=8<8 2  #:@0W=8 (?>40NBLAO 702V@5=V =0;56=8< G8=>< :>?VW @5TAB@0FV9=8E ?>A2V4G5=L C A:;04V B5=45@=>W ?@>?>78FVW). 4. "5@<V= ?@840B=>ABV ;V:0@AL:8E 70A>1V2 =0 <><5=B ?>AB02:8 ?>28=5= A:;040B8 =5 <5=H5 80% 2V4 7030;L=>3> B5@<V=C ?@840B=>ABV 7 4=O 702575==O WE =0 A:;04 0<>2=8:0. 5. #G0A=8: 7>1>2 O70=89 70157?5G8B8 ?>AB02:C (4>AB02:C) ;V:0@AL:8E 70A>1V2 4> 425@59 A:;04C 0<>2=8:0   25=83>@>4AL:0 , <.25=83>@>4:0, 2C;.. 5@>W2 515A=>W !>B=V,79, '5@:0AL:0 >1;.,#:@0W=0, 20202. 6. &V=8 70 >48=8FN B>20@C 70?@>?>=>20=V CG0A=8:>< ?>28==V D>@<C20B8AL, 73V4=> >AB0=>28 # 2V4 2 ;8?=O 2014 @. ! 240 @> @5D5@5=B=5 FV=>CB2>@5==O =0 ;V:0@AL:V 70A>18 B0 28@>18 <548G=>3> ?@87=0G5==O, I> 70:C?>2CNBLAO 70 :>HB8 45@602=>3> B0 <VAF528E 1N465BV2, >AB0=>28 # 2V4 17.10.2008 @. !955 @> 70E>48 I>4> AB01V;V70FVW FV= =0 ;V:0@AL:V 70A>18 V 28@>18 <548G=>3> ?@87=0G5==O 7V 7<V=0<8. 548:>  B5E=VG=V E0@0:B5@8AB8:8 (V:0@AL:V 70A>18 . Omeprazole, Drotaverine, Metoclopramide, Ondansetron, Enoxaparin, Tranexamic acid, Furosemide, Dexamethasone, Ceftriaxone, Azithromycin, Ammonia, Amiodarone, Metamizole sodium, Amikacin, Acetylcysteine, Oxybuprocaine, Bupivacaine, Verapamil, Heparin, Aciclovir, Diclofenac Pantoprazole, Isosorbide dinitrate, Anti-D (rh) immunoglobulin, Acetylcysteine, Imipenem and cilastatin, Phytomenadione, Captopril, Lidocaine, Bupivacaine, Drotaverine, Oxytocin, Multienzymes (lipase, protease etc.), Paracetamol, Pentoxifylline, Clopidogrel, Prednisolone, Neostigmine, Budesonide, Oxymetazoline, Formoterol and budesonide, Comb drug, Tobramycin, Tropicamide, Enoxaparin, Cefazolin, Cefotaxime, Cyanocobalamin, Ciprofloxacin, Ondansetron, Ketorolac,Cetirizine, Barbiturates in combination with other drugs, Comb drug, Castor oil, Medicinal charcoal, Haloperidol, Albumin, Aciclovir, Levothyroxine sodium, Medicinal charcoal, Ibuprofen) ><5@">@3>20 =0720 B0 D>@<0 28?CA:CV6=0@>4=0 =072048=8FO 28<V@CC?0:>2:81  . ;V>DV;V70B 4;O @>7G8=C 4;O V=DC7V9 ?> 40 <3, 1 D;0:>= 7 ;V>DV;V70B>< 2 ?0GFV Omeprazole C? 20002 " . >7G8= 4;O V='T:FV9, 20 <3/<; ?> 2 <; 2 0<?C;0E ! 5 Drotaverine C?8003" . >7G8= 4;O V='T:FV9, 5 <3/<; ?> 2 <; ?> 5 0<?C; C :>=BC@=V9 G0@C=:>2V9 C?0:>2FV; ?> 2 :>=BC@=V G0@C=:>2V C?0:>2:8 2 ?0GFV Metoclopramide C?1004!" . @>7G8= 4;O V='T:FV9, 2 <3/<; ?> 2 <; 2 0<?C;V; ?> 5 0<?C; C ?0GFV Ondansetron C?75$!. >7G8= 4;O V='T:FV9, 10000 0=B8-%0 /<; ?> 0,8 <; (8000 0=B8-%0 ) C H?@8F0E ! 2 Enoxaparin C?1006" . >7G8= 4;O V='T:FV9, 100 <3/<; ?> 5 <; 2 0<?C;0E ! 5 (5E1) C 1;VAB5@0E 2 ?0GFV 7 :0@B>=C Tranexamic acid C?5007$# !. >7G8= 4;O V='T:FV9 10 <3/<; ?> 2 <; 2 0<?C;V; ?> 5 0<?C; C :>=BC@=V9 G0@C=:>2V9 C?0:>2FV; ?> 2 :>=BC@=V G0@C=:>2V C?0:>2:8 2 ?0GFV Furosemide C?3008!". >7G8= 4;O V='T:FV9 , 4 <3/<; ?> 1 <; 2 0<?C;0E ! 5 Dexamethasone C?10009&$" !-. >@>H>: 4;O @>7G8=C 4;O V='T:FV9 ?> 1000 <3 C D;0:>=V ! 1 C ?0GFV Ceftriaxone $; 1100010&$" !. >@>H>: 4;O @>7G8=C 4;O V='T:FV9 ?> 0,5 3 C D;0:>=0E !10 Ceftriaxone C?2011. >@>H>: 4;O >@0;L=>W ACA?5=7VW, 100 <3/5 <; ?> 20 <; ACA?5=7VW @07>< 7 :0;V1@>2>G=8< H?@8F>< V <V@=>N ;>65G:>N 2 ?0GFV Azithromycin $; 1012# . >7G8= 4;O 7>2=VH=L>3> 70AB>AC20==O 10% ?> 40 <; C D;0:>=0E Ammonia* D;2013 ". B01;5B:8 ?> 200 <3, ?> 10 B01;5B>: C 1;VAB5@V; ?> 5 1;VAB5@V2 C ?0GFV 7 :0@B>=C Amiodarone C?6014,. >7G8= 4;O V='T:FV9 500 <3/<; ?> 2 <; 2 0<?C;0E ! 10 Metamizole sodium C?100015&. V>DV;V70B 4;O @>7G8=C 4;O V='T:FV9 ?> 1,0 3 C D;0:>=0E Amikacin C?8016 ". >7G8= 4;O V='T:FV9 50 <3/<;, ?> 3 <; 2 0<?C;0E ! 5 Amiodarone C?20017!" &. ?>@>H>: 4;O >@0;L=>3> @>7G8=C ?> 200 <3; ?> 3 3 C A0H5; ?> 10 A0H5 C :0@B>==V9 :>@>1FV Acetylcysteine C?5018!. @0?;V >G=V 0,4 % :>=B59=5@-:@0?5;L=8FO 10 <; N1 Oxybuprocaine C?1019# !. >7G8= 4;O V='T:FV9, 5 <3/<; ?> 4 <; 2 0<?C;0E ! 5 Bupivacaine C?2420 . >7G8= 4;O V='T:FV9, 2,5 <3/<; ?> 2 <; 2 0<?C;V; ?> 5 0<?C; C :>=BC@=V9 G0@C=:>2V9 C?0:>2FV; ?> 2 :>=BC@=V G0@C=:>2V C?0:>2:8 C ?0GFV Verapamil C?221 . @>7G8= 4;O V='T:FV9, 5000 /<; ?> 5 <; C D;0:>=0E; ?> 5 D;0:>=V2 C :>=BC@=V9 G0@C=:>2V9 C?0:>2FV; ?> 1 :>=BC@=V9 G0@C=:>2V9 C?0:>2FV 2 :0@B>==V9 :>@>1FV Heparin C?20022  . "01;5B:8 ?> 400 <3 ?> 10 B01;5B>: C 1;VAB5@V, ?> 1 1;VAB5@C 2 ?0GFV Aciclovir C?2023$. >7G8= 4;O V='T:FV9 25 <3/<; ?> 3 <; 2 0<?C;0E ! 5 Diclofenac C?40024". "01;5B:8, 2:@8BV >1>;>=:>N, :8H:>2>@>7G8==V ?> 40 <3 ! 30 (10E3) Pantoprazole C?10025-. >=F5=B@0B 4;O @>7G8=C 4;O V=DC7V9, 1 <3/<; ?> 10 <; 2 0<?C;0E ! 10 (5E2) Isosorbide dinitrate C?3526 . @>7G8= 4;O V= T:FV9, 1500  (300 <:3 V<C=>3;>1C;V=C) ?> 2 <; 2 0<?C;V, ?> 1 0<?C;V 2 ?0GFV Anti-D (rh) immunoglobulin C?1027!". >7G8= 4;O V='T:FV9, 100 <3/<; ?> 3 <; 2 0<?C;0E ! 10 Acetylcysteine C?428/&!"" >@>H>: 4;O ?@83>BC20==O @>7G8=C 4;O V=DC7V9, 500 <3/500 <3 10 A:;O=8E D;0:>=V2 7 ?>@>H:>< C :0@B>==V9 :>@>1FV Imipenem and cilastatin C?1029". >7G8= 4;O V='T:FV9, 10 <3/<;, ?> 1 <; 2 0<?C;V :>@8G=52>3> A:;0; ?> 5 0<?C; 2<VICNBL 2 C?0:>2:C 7 ?;V2:8 PVC; ?> 1 ?;0AB8:>2V9 C?0:>2FV 2 :0@B>==V9 :>@>1FV Phytomenadione C?5030" . "01;5B:8 ?> 25 <3, ?> 10 B01;5B>: C 1;VAB5@V; ?> 2 Z\   , 0 F H f h ŷtaRCRCRCRCRCRCRChQbh|r,B*mH phsH hQbh|r,B*mH"phsH"$hQbh|r,5B*PJmH"phsH"hQbh|r,0J:5mH"sH"h|r,0J:5mH"sH"h|r,h|r,0J:5mH"sH"h$hu5]mH"sH"h-^h~z5]mH"sH"h-^h}5]mH"sH"h-^h-$5]mH"sH"hu&h f?5]mH"sH"h f?5mH"sH"h55mH"sH"hKhJ:.5mH"sH"\) *  |ppp $`a$gd,p$a$gd,p"$ 2( Px 4 #\'*.25@9a$gd~z$a$gduc\$a$gdf5"$ 2( Px 4 #\'*.25@9a$gd  2( Px 4 #\'*.25@9gd $a$gd f?       ( ) ; < E F U V d e q r | }      * + 7 8 D E N O t u      * + 6 7 F G U V b c m n hQbh|r,B*mH phsH hQbh|r,B*mH"phsH"Yn x y    ' ( ) øÜҭ|g[Rh,p5mH"sH"h-^h-$5mH"sH")hf$8huB*CJPJaJmH"phsH"hQbhf$8B*mH"phsH" h|r,h|r,B*\mH"phsH" h|r,h|r,B*\mH phsH h|r,h|r,mH"sH"h|r,h|r,mH sH h|r,h|r,B*mH"phsH"h|r,h|r,B*mH phsH hQbh|r,B*mH"phsH"hQbh|r,B*mH phsH l|dl  RTtvxzkhQbh+B*mH"phsH"$hQbhf$85B*PJmH"phsH"hQbhf$80J:5mH"sH"hQb5]mH"sH"h}\h>"_mH"sH"hf$8hf$856]mH"sH"hyhf$85mH"sH"ho~mH"sH"h,pmH"sH"h`3h,p\mH"sH"h`3h,pmH"sH"hOtjh:&P5mH"sH"$v !"#$%&'( J l d$Ifgd>"_gdQb$a$gd,p X gd>"_"$ 2( Px 4 #\'*.25@9a$gdf$8 $`a$gd,p24RTln  12;<KLZ[ghrs{|   !-.:;DEjôhQbhQbB*mH"phsH"hQbhQbB*mH phsH hQbhVv B*mH"phsH"hQbhVv B*mH phsH hQbh+B*mH"phsH"hQbh+B*mH phsH Ajkwx   !,-<=KLXYcdnoøh|r,h|r,B*mH"phsH"h|r,h|r,B*mH phsH h|r,h|r,mH"sH"h|r,hQbmH sH h|r,hQbB*mH"phsH"h|r,hQbB*mH phsH hQbhQbB*mH phsH hQbhQbB*mH"phsH"2%&' & ϵ|iTC h;h>"_OJQJ^JnH tH (h;h>"_OJQJ^JmH nH sH tH %hQbh>"_B*CJaJmH"phsH"%hQbhQbB*CJaJmH"phsH"%hQbhQbB*CJaJmH phsH %h|r,hQbB*CJaJmH phsH h|r,hQbmH"sH"h|r,h|r,B*mH"phsH"h|r,h|r,B*mH phsH  h|r,h|r,B*\mH"phsH" h|r,h|r,B*\mH phsH & J n V!p!!!!!!!","2"4":"<">"@"Z"Ƴu`Ƴu`ƳPh@Z*B*CJaJmH"phsH")hBhg&BB*OJQJ^JmH"phsH"h@Z*B*CJaJmH"phsH"hWhg&BB*CJaJphh@Z*B*CJaJph%hWhg&BB*CJaJmH"phsH"$hWhg&BCJaJmH"nH sH"tH h|r,CJaJmH"nH sH"tH (h;h>"_OJQJ^JmH nH sH tH (h;h>"_OJQJ^JmH"nH sH"tH  2hd$If^hgd>"_m$kd$$IflrO g%ffff t0644 lBBayt@Z*d$Ifgd>"_ V!X!n!p!v!!!!""*","2":"<"@"R#T#r#Ff/ $$Ifa$gdf$8hd$If^hgd>"_m$Ff $Ifgd>"_ $Ifgdf$8 $Ifgd@Z* $Ifgdg&BZ"R#T#r#z#~#####@$H$J$L$N$P$R$ %"%ٺ٥ٺ٥o\M>h|r,hg&BB*CJaJphh|r,h@Z*B*CJaJph$h|r,hg&BCJaJmH"nH sH"tH $h|r,h|r,CJaJmH"nH sH"tH $hWhg&BCJaJmH"nH sH"tH h|r,CJaJmH"nH sH"tH )hBhg&BB*OJQJ^JmH"phsH"h@Z*B*CJaJmH"phsH"hWhg&BB*CJaJph%hWhg&BB*CJaJmH"phsH"%h@Z*h@Z*B*CJaJmH"phsH"r#t#z####&$($@$B$H$L$N$R$ % %"%$%*% $Ifgd@Z*d$Ifgd|r,m$Ff[ $Ifgdf$8hd$If^hgd>"_m$Ff $$Ifa$gdf$8 $Ifgd>"_ $Ifgdg&B"%*%,%2%4%6%8%H%% &&&,&.&0&2&4&T'j'r'x'z'|'~''"(*(2(4(ĴzgWgĴgzgWgĴzgGghB*CJaJmH"phsH"h@Z*B*CJaJmH"phsH"%hWhg&BB*CJaJmH"phsH"hWhg&BB*CJaJphh@Z*B*CJaJphh B*CJaJph$hWhg&BCJaJmH"nH sH"tH h|r,CJaJmH"nH sH"tH )hBhg&BB*OJQJ^JmH"phsH"%h|r,h@Z*B*CJaJmH"phsH"%h|r,hg&BB*CJaJmH"phsH"*%2%4%8%%%& &&&.&0&4&R'T'j'l'r'z'|''((FfFf $Ifgd>"_ $Ifgdg&B $Ifgd@Z*hd$If^hgd>"_m$Ff $$Ifa$gdf$8("($(*(4(6(:(((((( ) )))))))))Ff" $IfgdFfIhd$If^hgd>"_m$Ff $$Ifa$gdf$8 $Ifgd>"_ $Ifgdg&B4(6(8(:((((() ) )))))))))ǸubVG4%hWhB*CJaJmH"phsH"hWhB*CJaJphhB*CJaJph$hWhCJaJmH"nH sH"tH hCJaJmH"nH sH"tH hB*CJaJmH"phsH"h B*CJaJmH"phsH"%hWhg&BB*CJaJmH"phsH"hWhg&BB*CJaJph$hWhg&BCJaJmH"nH sH"tH h|r,CJaJmH"nH sH"tH )hBhg&BB*OJQJ^JmH"phsH")))))******+++++++++f,h,~,,,,,,--8-ʺxcʛTxcʛTxcʛTh|+h|+B*CJaJph)hBh|+B*OJQJ^JmH"phsH"h|+B*CJaJmH"phsH"%h|+h|+B*CJaJmH"phsH"h|+B*CJaJph%h|+h|+B*CJaJmH"phsH"h B*CJaJmH"phsH"h|+CJaJmH"nH sH"tH h|r,CJaJmH"nH sH"tH )hBhB*OJQJ^JmH"phsH"))*******+++++++++f,h,~,,Ff *Ffu& $$Ifa$gdf$8 $Ifgd>"_ $Ifgd $Ifgd|+hd$If^hgd>"_m$,,,,,--8-:-@-J-L-R---------v.Ff4Ff71 $Ifgd $Ifgd|+hd$If^hgd>"_m$Ff- $$Ifa$gdf$8 $Ifgd>"_8-:-J-L-P-R-^---------v.x.......f/h///////00.000<0>0B0D0˻q˻q˻q˻q˻%h|+h|+B*CJaJmH"phsH"h|+h|+B*CJaJphh|+B*CJaJphh B*CJaJphh|+CJaJmH"nH sH"tH h|r,CJaJmH"nH sH"tH )hBh|+B*OJQJ^JmH"phsH"h|+B*CJaJmH"phsH"h|+h|+B*CJaJph&v.x.......f/h///////00.00060<0Ff;hd$If^hgd>"_m$Ffc8 $$Ifa$gdf$8 $Ifgd>"_ $Ifgd|+ $Ifgd<0>0D000000000 2"26282>2B2D2J233 $Ifgd<\kFfFFf%C $$Ifa$gdf$8 $Ifgd>"_ $Ifgd $Ifgd|+hd$If^hgd>"_m$Ff?D000000001"26282B2D2H2J2X2333333ͽxͽhUI9h<\kB*CJaJmH"phsH"h<\kB*CJaJph%h<\kh<\kB*CJaJmH"phsH"h B*CJaJmH"phsH"h|+B*CJaJmH"phsH"h|+CJaJmH"nH sH"tH h|r,CJaJmH"nH sH"tH )hBh|+B*OJQJ^JmH"phsH"h|+B*CJaJmH"phsH"%h|+h|+B*CJaJmH"phsH"h|+B*CJaJph%h|+h|+B*CJaJmH"phsH"3333333V4X4l4n4t4z4|445555 5(5*5Ff}QFfM $$Ifa$gdf$8hd$If^hgd>"_m$FfQJ $Ifgd>"_ $Ifgd $Ifgd<\k3333333V4X4l4n4r4t4x4z4|44445(5*5.505@555555ʺpʺ`K`K`)hBh<\kB*OJQJ^JmH"phsH"h<\kCJaJmH"nH sH"tH %h|+h|+B*CJaJmH"phsH"h<\kh|+B*CJaJphh<\kB*CJaJphh B*CJaJphh|+CJaJmH"nH sH"tH h|r,CJaJmH"nH sH"tH )hBh|+B*OJQJ^JmH"phsH"h|+B*CJaJmH"phsH"h<\kB*CJaJmH"phsH"*50555555555666666667777 $Ifgdu37FfXFfU $$Ifa$gdf$8 $Ifgd>"_ $Ifgd<\khd$If^hgd>"_m$5666666777777888888888999::p;|;~;;²s^Os^s^s^hu37hu37B*CJaJph)hBhu37B*OJQJ^JmH"phsH"hu37B*CJaJmH"phsH"hu37B*CJaJph%hu37hu37B*CJaJmH"phsH"hu37CJaJmH"nH sH"tH h|r,CJaJmH"nH sH"tH )hBh<\kB*OJQJ^JmH"phsH"h<\kB*CJaJmH"phsH"h<\kB*CJaJphh B*CJaJph77778888888889999999:N;FfkcFf_ $Ifgd<\k $Ifgdu37hd$If^hgd>"_m$Ff?\ $$Ifa$gdf$8 $Ifgd>"_N;P;n;p;v;|;~;;"|$|8|:|@|H|J|P|} }} }&},}.}Ff-nFfjhd$If^hgd>"_m$Ffg $$Ifa$gdf$8 $Ifgd>"_ $Ifgdu37;;<|:|@|F|H|J|N|P| },}.}2}4}}}}}}~~~~ 02ҭҭҭҭҭҭzg%h=hu37B*CJaJmH"phsH"%h=h=B*CJaJmH"phsH"h=B*CJaJmH"phsH"h|r,CJaJmH"nH sH"tH )hBhu37B*OJQJ^JmH"phsH"h;XB*CJaJmH"phsH"hu37B*CJaJmH"phsH"Uhu37B*CJaJphhu37CJaJmH"nH sH"tH &1;VAB5@8 2 ?0GFV Captopril C?10031 .@>7G8= 4;O V='T:FV9100 <3/<; ?> 2 <; 2 0<?C;V ! 10 C 1;VAB5@V C :0@B>==V9 :>@>1FV Lidocaine C?3032!". @>7G8= 4;O V='T:FV9, 2,5 <3/<;, ?> 200 <; C ?;OH:0E Bupivacaine C?20033 . B01;5B:8, 2:@8BV ?;V2:>2>N >1>;>=:>N, ?> 75 <3; ?> 10 B01;5B>: C 1;VAB5@V; ?> 3 1;VAB5@8 C ?0GFV Acetylsalicylic acid C?10034. !#,$". >7G8= 4;O V='T:FV9, 250 <3/<; ?> 5 <; 2 0<?C;0E ! 10 (5E2) Magnesium sulfate C?40035". @>7G8= 4;O V='T:FV9, 10 <3/<; ?> 1 <; 2 0<?C;V; ?> 1 <; 2 0<?C;V; ?> 10 0<?C; C 1;VAB5@V; ?> 1 1;VAB5@C C ?0GFV Phenylephrine C?13036" . "!#,$". @>7G8= 4;O V='T:FV9, 300 <3/<; ?> 5 <; 2 0<?C;V; ?> 5 0<?C; C :>=BC@=V9 G0@C=:>2V9 C?0:>2FV; ?> 2 :>=BC@=V G0@C=:>2V C?0:>2:8 2 ?0GFV Thiosulfate C?5037#". >7G8= 4;O V=30;OFV9 1 <3/<; ?> 2 <; :>=B59=5@0E >4=>4>7>28E ! 10 (10E1), C ?0:5B0E 7 ?>;V<5@=>W ?;V2:8 C ?0GFV Salbutamol #? 4038!". @>7G8= 4;O V='T:FV9, 5 <3/<; ?> 5 <; C D;0:>=0E ! 10 (5E2)* Bupivacaine C?15039%(  "". @>7G8= 4;O V='T:FV9, 20 <3/<;, ?> 2 <; 2 0<?C;V; ?> 5 0<?C; C 1;VAB5@V; ?> 1 1;VAB5@C 2 ?0GFV Drotaverine C?1240!"&-. >7G8= 4;O V='T:FV9, 5 /<; ?> 1 <; 2 0<?C;0E ! 10 Oxytocin C?7041 " 8000. "01;5B:8 30AB@>@578AB5=B=V ! 50 (10E5) C 1;VAB5@0E Multienzymes (lipase, protease etc.) C?1042 $#. @>7G8= 4;O V=DC7V9 10 <3/<; ?> 100 <; C D;0:>=V, ?> 10 D;0:>=V2 C :0@B>==V9 C?0:>2FV Paracetamol C?6543"!$. @>7G8= 4;O V='T:FV9, 20 <3/<; ?> 5 <; 2 0<?C;V; ?> 5 0<?C; C :>=BC@=V9 G0@C=:>2V9 C?0:>2FV, ?> 2 :>=BC@=V G0@C=:>2V C?0:>2:8 2 ?0GFV Pentoxifylline C?20044" . "01;5B:8, 2:@8BV >1>;>=:>N, ?> 75 <3 ! 28 (14E2) C 1;VAB5@0E Clopidogrel C?1045 . >7G8= 4;O V='T:FV9, 30 <3/<; ?> 1 <; 2 0<?C;0E ! 3 Prednisolone C?746  . >7G8= 4;O V='T:FV9, 0,5 <3/<; ?> 1 <; 2 0<?C;0E ! 10 (5E2) Neostigmine C?3047#! !"  . ACA?5=7VO 4;O @>7?8;5==O, 0,5 <3/<; ?> 2 <; C :>=B59=5@V; ?> 5 :>=B59=5@V2, C :>=25@BV; ?> 4 :>=25@B8 C :0@B>==V9 :>@>1FV Budesonide C?2048 . :@0?;V =070;L=V, 0,5 <3/<; ?> 10 <; C D;0:>=V A:;O=><C 1@C=0B=>3> :>;L>@C 70:C?>@5=><C :@0?5;L=8F5N; ?> 1 D;0:>=C 2 ?0GFV Oxymetazoline C?7049 . :@0?;V =070;L=V, 0,1 <3/<; ?> 10 <; C D;0:>=V A:;O=><C 70:C?>@5=><C :@0?5;L=8F5N; ?> 1 D;0:>=C 2 ?0GFV 7 :0@B>=C Oxymetazoline C?2050! " "# #% . >@>H>: 4;O V=30;OFV9, 4>7>20=89, 160 <:3/4,5 <:3/4>70(604>7), ?> 60 4>7 C ?;0AB8:>2><C V=30;OB>@V; ?> 1 V=30;OB>@C 2 :0@B>==V9 :>@>1FV Formoterol and budesonide C?251! " "# #% . >@>H>: 4;O V=30;OFV9, 4>7>20=89, 80 <:3/4,5 <:3/4>70 (604>7), ?> 60 4>7 C ?;0AB8:>2><C V=30;OB>@V; ?> 1 V=30;OB>@C 2 :0@B>==V9 :>@>1FV Formoterol and budesonide C?252! $  . "01;5B:8, 2:@8BV >1>;>=:>N, 7 <>48DV:>20=8< 282V;L=5==O<, ?> 320 <3/60 <3 ?> 30 B01;5B>: C A:;O=><C D;0:>=V; ?> 1 D;0:>=C 2 :0@B>==V9 C?0:>2FV Comb drug C?453" &. @0?;V >G=V, 3 <3/<; ?> 5 <; C D;0:>=V; ?> 1 D;0:>=C @07>< V7 :@8H:>N-:@0?5;L=8F5N 2 ?0GFV Tobramycin C?1054" . @0?;V >G=V 1 % ?> 10 <; C D;0:>=0E ! 1 Tropicamide C?1055! . >7G8= 4;O V='T:FV9, 10000 0=B8-%0 /<; ?> 0,4 <; (4000 0=B8-%0 ) 2 ?>?5@54=L> =0?>2=5=8E H?@8F0E ! 1 Enoxaparin C?80056! . >7G8= 4;O V='T:FV9, 10000 0=B8-%0 /<; ?> 0,6 <; (6000 0=B8-%0 ) 2 ?>?5@54=L> =0?>2=5=8E H?@8F0E ! 1 (1E1) Enoxaparin C?8057&$ . >@>H>: 4;O ?@83>BC20==O @>7G8=C 4;O V='T:FV9 ?> 1000 <3 C D;0:>=0E Cefazolin D;200058&$"! . >@>H>: 4;O @>7G8=C 4;O V='T:FV9 ?> 1000 <3 C D;0:>=0E Cefotaxime D;350059&. @>7G8= 4;O V='T:FV9, 0,5 <3/<;, ?> 1 <; 2 0<?C;V; ?> 5 0<?C; C :>=BC@=V9 G0@C=:>2V9 C?0:>2FV; ?> 2 :>=BC@=V G0@C=:>2V C?0:>2:8 2 ?0GFV Cyanocobalamin C?6060& $!&. "01;5B:8, 2:@8BV >1>;>=:>N, ?> 0,5 3 ! 10 (10E1) C 1;VAB5@V Ciprofloxacin C?2061!" . >7G8= 4;O V='T:FV9, 2 <3/<; ?> 2 <; 2 0<?C;0E ! 5 Ondansetron C?8062!" . >7G8= 4;O V='T:FV9, 2 <3/<; ?> 4 <; 2 0<?C;0E ! 5 Ondansetron C?16063&" . "01;5B:8, 2:@8BV ?;V2:>2>N >1>;>=:>N, ?> 10 <3 ! 20 (10E2) Cetirizine C?264". @>7G8= 4;O V='T:FV9, 30 <3/<;, ?> 1 <; 2 0<?C;V; ?> 5 0<?C; C :>=BC@=V9 G0@C=:>2V9 C?0:>2FV; ?> 2 :>=BC@=V G0@C=:>2V C?0:>2:8 2 ?0GFV Ketorolac C?1065 . @0?;V >@0;L=V, @>7G8= ?> 25 <; C D;0:>=0E ! 1 Barbiturates in combination with other drugs C?566./ '.@>7G8= 4;O 7>2=VH=L>3> 70AB>AC20==O ?> 25 3 C D;0:>=0E Comb drug D;567 & /. ;VO ?> 100 <; C D;0:>=0E Castor oil D;568 . @>7G8= 4;O V='T:FV9, 5 <3/<;, ?> 1 <; 2 0<?C;V; ?> 10 0<?C; C 1;VAB5@V; ?> 1 1;VAB5@C 2 :>@>1FV 7 :0@B>=C Haloperidol C?1069,#. @>7G8= 4;O V=DC7V9, 10 % ?> 100 <; C D;0:>=V; ?> 1 D;0:>=C C ?0GFV 7 :0@B>=C Albumin C?1070  . >@>H>: 4;O @>7G8=C 4;O V='T:FV9 ?> 250 <3 C D;0:>=0E ! 10E1 C :>=BC@=8E G0@C=:>28E C?0:>2:0E C ?0GFV Aciclovir C?571L-" !. "01;5B:8 ?> 50 <:3 ! 50 (10E5) C 1;VAB5@0E Levothyroxine sodium C?2072L-" !. "01;5B:8 ?> 100 <:3 ?> 10 B01;5B>: C 1;VAB5@V, ?> 5 1;VAB5@V2 C ?0GFV Levothyroxine sodium C?2073#/ " . "01;5B:8 ?> 250 <3 ! 10 (10E1) Medicinal charcoal C?7074$.!CA?5=7VO >@0;L=0, 100 <3/5 <; ?> 100 <; Ibuprofen D;200*2AV ?>A8;0==O =0 B>@3>25;L=C <0@:C, DV@<C, ?0B5=B, :>=AB@C:FVN 01> B8? ?@54<5B0 70:C?V2;V, 465@5;> 9>3> ?>E>465==O 01> 28@>1=8:0 A;V4 G8B0B8 O: 01> 5:2V20;5=B, O:89 2:;NG5=89 4> 5@5;V:C ;V:0@AL:8E 70A>1V2, 4>72>;5=8E 4> 70:C?V2;V 70 1N465B=V :>HB8. .}4}}}}}}}}}~~~~~~~FfYuFfq $$Ifa$gdf$8 $Ifgd>"_ $Ifgdu37hd$If^hgd>"_m$Ȁʀ02JLRXZ`VXFf $Ifgd=Ff| $Ifgd>"_ $Ifgdu37hd$If^hgd>"_m$Ffx $$Ifa$gdf$82JLPRVXZ^`rVXnpvx|~0268>@BFH&(@BнЭxl]ЭЭx]ЭЭx]h=hu37B*CJaJphh B*CJaJphhu37CJaJmH"nH sH"tH h|r,CJaJmH"nH sH"tH )hBhu37B*OJQJ^JmH"phsH"hu37B*CJaJmH"phsH"%h=hu37B*CJaJmH"phsH"h=B*CJaJmH"phsH"%h=hu37B*CJaJmH"phsH"h=B*CJaJph$Xnpx~028@BH&(@BHNPFf݊FfG $$Ifa$gdf$8hd$If^hgd>"_m$Ff $Ifgd>"_ $Ifgdu37 $Ifgd=BFHLNPTV ҇؇܇އ02@BFHZ؉ʺyffZh B*CJaJph%h=h=B*CJaJmH"phsH"h;XB*CJaJmH"phsH")hBh=B*OJQJ^JmH"phsH"h=B*CJaJphh=CJaJmH"nH sH"tH h|r,CJaJmH"nH sH"tH )hBhu37B*OJQJ^JmH"phsH"hu37B*CJaJmH"phsH"h=B*CJaJmH"phsH"!PV Ї҇؇Ff Ffs $$Ifa$gdf$8 $Ifgd>"_ $Ifgd=hd$If^hgd>"_m$؇އ028@BH؉ډFf˜Ff5 $Ifgd>"_ $Ifgd=hd$If^hgd>"_m$Ff $$Ifa$gdf$8؉ډʊ̊DF^`lnrtČƌ،p^#h=B*CJOJQJ^JaJphh B*CJaJmH"phsH"h B*CJaJphh=CJaJmH"nH sH"tH h|r,CJaJmH"nH sH"tH )hBh=B*OJQJ^JmH"phsH"h=B*CJaJmH"phsH"%h=h=B*CJaJmH"phsH"h=B*CJaJphh=h=B*CJaJph$DF^`flntƌЍFfFfhd$If^hgd>"_m$Ffa $$Ifa$gdf$8 $Ifgd>"_ $Ifgd=Ѝҍ"(*0ln $IfgdMRFfhd$If^hgd>"_m$Ff# $$Ifa$gdf$8 $Ifgd>"_ $Ifgd= "&(*.0ȸn^^ȸNB^hMRB*CJaJphhMRCJaJmH"nH sH"tH hMRB*CJaJmH"phsH"%h=h=B*CJaJmH"phsH"h=h=B*CJaJphh=B*CJaJphh B*CJaJphh=CJaJmH"nH sH"tH h|r,CJaJmH"nH sH"tH )hBh=B*OJQJ^JmH"phsH"h=B*CJaJmH"phsH"#h=B*CJOJQJ^JaJph(*.0246:<prhj $&(,.DʺʺʺʺʺhFB*CJaJphhMRB*CJaJphh\rB*CJaJphhMRCJaJmH"nH sH"tH h|r,CJaJmH"nH sH"tH )hBhMRB*OJQJ^JmH"phsH"hMRB*CJaJmH"phsH"h\rB*CJaJmH"phsH"4(*046<prhjFf{Ff $$Ifa$gdf$8 $Ifgd>"_ $Ifgd= $Ifgd\rhd$If^hgd>"_m$FfO &(.24:BDJFf=Ff $Ifgd\rhd$If^hgd>"_m$Ff $$Ifa$gdf$8 $Ifgd>"_ $Ifgd=D248:@BDHJBDZ\`bfhjnp&(,.68:>@TDzvvDzjvvDzZjhFCJaJmH"nH sH"tH h B*CJaJphhFB*CJaJmH"phsH"hFB*CJaJphhMRCJaJmH"nH sH"tH h|r,CJaJmH"nH sH"tH )hBhMRB*OJQJ^JmH"phsH"hMRB*CJaJmH"phsH"h\rB*CJaJmH"phsH"hMRB*CJaJphh\rB*CJaJph#JBDZ\bhjp&(.8:@ȘʘFfihd$If^hgd>"_m$Ff $$Ifa$gdf$8 $Ifgd>"_ $Ifgd= $IfgdFT(*HJNPTVX\^ "$(*ξ|llξ|]|llξM|hd_CJaJmH"nH sH"tH hd_hFB*CJaJphhd_B*CJaJmH"phsH"hd_B*CJaJph%hd_hFB*CJaJmH"phsH"%hd_hd_B*CJaJmH"phsH"hFCJaJmH"nH sH"tH h|r,CJaJmH"nH sH"tH )hBhFB*OJQJ^JmH"phsH"hFB*CJaJmH"phsH"hFB*CJaJph(*HJPVX^"$*Ff+Ff $Ifgd>"_ $Ifgd= $Ifgdd_hd$If^hgd>"_m$Ff $$Ifa$gdf$8ěƛқԛ؛ڛZ\tv*,68<>DN`tvŰ}Űq}Ű}a}}Űqh B*CJaJmH"phsH"h B*CJaJph%hd_hd_B*CJaJmH"phsH"hd_CJaJmH"nH sH"tH h|r,CJaJmH"nH sH"tH )hBhd_B*OJQJ^JmH"phsH"hd_B*CJaJmH"phsH"h Hhhd_B*CJaJphhd_B*CJaJphhd_hd_B*CJaJph$ěƛ̛қԛڛZ\tv|*,268FfFfWhd$If^hgd>"_m$Ff $$Ifa$gdf$8 $Ifgd>"_ $Ifgd= $Ifgdd_8>^`tv|XZ`dfl FfFf $$Ifa$gdf$8 $Ifgd>"_ $Ifgd= $Ifgdd_hd$If^hgd>"_m$Zdfjl  ǷyǷǷm^m^K%hd_hd_B*CJaJmH"phsH"hd_hd_B*CJaJphh|r,B*CJaJph%hd_hd_B*CJaJmH"phsH"hd_hd_B*CJaJphhd_B*CJaJphhd_CJaJmH"nH sH"tH h|r,CJaJmH"nH sH"tH )hBhd_B*OJQJ^JmH"phsH"hd_B*CJaJmH"phsH"%hd_hd_B*CJaJmH phsH  rt $Ifgd|r,dd$@&If[$\$gd|r, $Ifgd|r,FfE $Ifgdd_hd$If^hgd>"_m$Ff $$Ifa$gdf$8 $Ifgd>"_dfvx~lǷwdOC7h|r,B*CJaJphh B*CJaJph)hBh|r,B*OJQJ^JmH"phsH"%hd_h|r,B*CJaJmH"phsH"%h|r,h|r,B*CJaJmH"phsH"h|r,h|r,5CJaJh|r,h|r,CJKH$PJ\aJ h|r,h|r,B*CJ\aJphh|r,CJaJmH"nH sH"tH )hBhd_B*OJQJ^JmH"phsH"%hd_hd_B*CJaJmH"phsH"h|r,B*CJaJmH"phsH"dfvx~lnFfq $$Ifa$gdf$8 $Ifgd>"_ $Ifgdd_dd$@&If[$\$gdd_ $Ifgd|r,hd$If^hgd>"_m$Ff $$Ifa$gd|r,ln0268<>@FZ"$&,¥ĥȥʥ̥ҥ02FHLNTVXǴǴǴǴǴǴǴǴǴǴh B*CJaJphh|r,CJaJmH"nH sH"tH )hBh|r,B*OJQJ^JmH"phsH"%hd_h|r,B*CJaJmH"phsH"h|r,B*CJaJmH"phsH"hd_h|r,5CJaJh|r,B*CJaJphhd_h|r,CJKH$PJ\aJ2028>@F$&,Ff3Ff $$Ifa$gdf$8 $Ifgd>"_ $Ifgdd_dd$@&If[$\$gdd_ $Ifgd|r,hd$If^hgd>"_m$Ff,ĥʥ̥ҥ02FHNVXTV$a$gd-$Ff_hd$If^hgd>"_m$Ff $$Ifa$gdf$8 $Ifgd>"_ $Ifgdd_dd$@&If[$\$gdd_ $Ifgd|r,XRTVXZhCJaJmH"sH"hW\mH"sH"h-^h6mH"sH"hI,6mH"sH"h-^h$6mH"sH"VXZ$a$gd21h:p f?. A!n"T#T$T% $$If!vh55555#v#v#v#v#v:V l t065555599BByt@Z*$$If!vh55555#v#v#v#v#v:V lJ  t206,,5555599/ /  / BBp2yt@Z*kd$$IflJrO g%&FFg  t20644 lBBap2yt@Z*$$If!vh55555#v#v#v#v#v:V lJ  t206,,5555599/ /  / BBp2yt@Z*kd$$IflJrO g%&FFg  t20644 lBBap2yt@Z*$$If!vh55555#v#v#v#v#v:V lJ  t206,,5555599/ /  / BBp2yt@Z*kd"$$IflJrO g%&FFg  t20644 lBBap2yt@Z*$$If!vh55555#v#v#v#v#v:V lJ  t206,,5555599/ /  / BBp2yt@Z*kd $$IflJrO g%&FFg  t20644 lBBap2yt@Z*$$If!vh55555#v#v#v#v#v:V lJ  t206,,5555599/ /  / BBp2yt@Z*kdN$$IflJrO g%&FFg  t20644 lBBap2yt@Z*$$If!vh55555#v#v#v#v#v:V lJ  t206,,5555599/ /  / BBp2yt@Z*kd$$IflJrO g%&FFg  t20644 lBBap2yt@Z*$$If!vh55555#v#v#v#v#v:V lJ  t206,,5555599/ /  / BBp2yt@Z*kdz$$IflJrO g%&FFg  t20644 lBBap2yt@Z*$$If!vh55555#v#v#v#v#v:V lJ  t206,,5555599/ /  / BBp2yt@Z*kd$$IflJrO g%&FFg  t20644 lBBap2yt@Z*$$If!vh55555#v#v#v#v#v:V lJ  t206,,5555599/ /  / BBp2yt@Z*kd$$IflJrO g%&FFg  t20644 lBBap2yt@Z*$$If!vh55555#v#v#v#v#v:V lJ  t206,,5555599/ /  / BBp2yt@Z*kd;>2>: 1dd@&[$\$5CJ0KH$PJ\aJ0BA B A=>2=>9 H@8DB 0170F0Xi@X 1KG=0O B01;8F04 l4a .k . 5B A?8A:0 0/0 Xt0 5B A?8A:01 Xtp !5B:0 B01;8FK7:V0 CJOJPJQJ^JaJmHsHJ J Xt0 "5:AB 2K=>A:8CJOJQJaJtH\/!\ Xt0"5:AB 2K=>A:8 =0: CJOJPJQJ^JaJmHsHT^2T Xt0 1KG=K9 (251)dd[$\$PJmH sH tH fBf Xt  170F A?8A:0d^m$CJOJPJQJ^JaJtH  Xtp!5B:0 B01;8FK17:V0 CJOJPJQJ^JaJmHsH Xtp!5B:0 B01;8FK27:V0CJOJPJQJ^JaJe r Xt0!B0=40@B=K9 HTML7 2( Px 4 #\'*.25@9 CJOJPJQJaJmHsHtHN/N Xt0!B0=40@B=K9 HTML =0: OJQJ^J^/^ Xt05@E=89 :>;>=B8BC;1  %CJPJaJtHN/N Xt05@E=89 :>;>=B8BC; =0:mHsH\/\ Xt086=89 :>;>=B8BC;1  %CJPJaJtHL/L Xt086=89 :>;>=B8BC; =0:mHsHL L Xt5@E=89 :>;>=B8BC;  %`/` Xt5@E=89 :>;>=B8BC; =0:1CJPJaJmHsHtHJ J  Xt86=89 :>;>=B8BC;  %^/^ Xt86=89 :>;>=B8BC; =0:1CJPJaJmHsHtH IS!5B:0 B01;8FK37:V!0!$CJOJPJQJ^JaJmHsHtHb/"b VStandard"*$1$8$9D(CJKHPJ^J_H)aJmHnHsHtH2!22 V Text body#x<!B< VTable Contents$ $/R VC=:BK3%$$$x*$-D1$5$8$9DM a$656;B* CJKHOJQJ^J_HmHph sHtH v!bv V$A=>2=>9 B5A:A 157 >BABC?0 =0: =0:&-DM D/qD VA=>2=>9 H@8DB 0170F01,,VWW8Num3( F,,VWWNum24) F,,VWWNum25* F**VWWNum3+ F,,VWWNum19, F</< VCharacter_20_styleJ/J V ListLabel 259CJPJ^JmHsHtHF/F V ListLabel 260CJ^JmHsHtHT/T V ListLabel 261"56CJPJ^JaJmHsHtH>/> V ListLabel 183 CJ^JaJ6/!6 V ListLabel 184^J,1,VWW8Num43 F6/A6 V ListLabel 190^J>/Q> V ListLabel 191 CJ^JaJN/aN V ListLabel 249CJPJ^JaJmHsHtHJ/qJ V ListLabel 250CJ^JaJmHsHtH0/0 8+ xfm_89183548"/" qrvts0,o, I, ng-binding,W, [L`!B@>3895\JJ d_03>;>2>: 1 =0:5CJ0KH$\aJ0PK![Content_Types].xmlj0Eжr(΢Iw},-j4 wP-t#bΙ{UTU^hd}㨫)*1P' ^W0)T9<l#$yi};~@(Hu* Dנz/0ǰ $ X3aZ,D0j~3߶b~i>3\`?/[G\!-Rk.sԻ..a濭?PK!֧6 _rels/.relsj0 }Q%v/C/}(h"O = C?hv=Ʌ%[xp{۵_Pѣ<1H0ORBdJE4b$q_6LR7`0̞O,En7Lib/SeеPK!kytheme/theme/themeManager.xml M @}w7c(EbˮCAǠҟ7՛K Y, e.|,H,lxɴIsQ}#Ր ֵ+!,^$j=GW)E+& 8PK!Ƶtheme/theme/theme1.xmlYnE#;8U i-qN3'JH DA\8 R>CW]{'ސ{g?x݈]"$q+_,y>8{7 K }xLވHe 2{Rܜaˋ??<ߟdžSr$L].<İT̟72S"ѵ_JwL&BJ05kZVyVy|xC OO|x>+<>@(:??/>5{yxFDdm 3^q5'=q6nib-$RB}}YGq=xK@;)^qbha79g . pUʹ;bbmc[$c'a}5KKfH5HL!ݦ&|mK{N6M6hq v|y 58+zH  *~ HHy\K*t@G>{sA}"))y sGfۡqǾ'w E1 [8>ܤ4Aбt׎~ls14_>,Ȭ7TT GqME=w-i>mo[oiBszbP:j5if F 9Pɉ* k\ A ;!N`.{I SցD p3˅5veU}AbvyA/g 氚 Z N+lR~aeԩj9&&CLgMʼn7a A0ƀHEA3~{q q1vƨl効9)>൜fN1N FIrdq8Y^:_73.|3 f%Jش?MOY s 3;} Rc0`d[鯠$ÿ - έhǴ"P 6T{TUٴ+9E28Y*MOt0O9Bݍqg7Ŕ9O)z?7#]u rBIHAאTpl>՟,SpT4@~BA%}'0+{eRF&rĪ#uu\{BHuM6`pG}N+!'_oN콶3a3dXZzCyCUɪ嶂ZZZ۱f,fAg-@`g v6V?Dhf6t=M&ʺ6ײ'݉#֚>d8s9xN=ڮjAv11;u2%M2oN1uo%տPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 +_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!Ƶtheme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] 2  n j& Z""%4()8-D035;2B؉DTlXZ !"$%&'*,/0368:=WY\_`cegjlnq r#*%(),v.<03*57N;.}XP؇ЍJ8,VZ#()+-.124579;<UVXZ[]^abdfhikmopr8@0(  B S  ?EG(*4=EGUWdfqs|!*,79DFNP\v!*,68FWbdmnxs y z   % ' 3 > H J T ] e g u w   $ & 4 6 ? A J L W Y d f n p |    & ( 3 5 ? A J L V X f w !RWX_`ew  &,19[fhj  #).6JP_dfqsu 4=@EFGQ[\`bd  &+3Ubdf"-/1jlsu"$Zbiruz{| &<DFHY_dl)/04;P[hjlclnp"$&]eltw|~6BDFgnsz  ,2468FHJ\bgo&'.089<=GIK\bgo  CKRZ]bdmoq $+-8:<Y_`ijs()024FLQYnt kvxz ! ' , 4 ^ i k m !!!"!D!L!N!P!r!!!!!!!!!!!!!!!!!!"""""#"$","."9";"="T"["p"r"x"z""""" ####4#=#?#J#L#N#c#i#n#v##########$$$$$-$2$<$R$\$c$n$r$z$$$$$$$$$$$$$$$$$$$$%% % %%%#%4%9%;%H%J%L%_%e%f%n%%%%%%%%%%%%%%%%% &&& &X&b&i&s&v&&&&&&&&&&&&&&&&'%','6'9'B'C'J'L'V'W'Z'['e'g'i''''''''''''''''(( ( ((((((+(1(2(6(J(Q(f(h(i(}((((((((((((((((() )))/)6)=)G)H)R)`)j)l)n)))))))))))))))**"*.*/*6*;*C*[*d*f*h***********++g+u+w+y++++++++++++++,(,3,5,7,L,R,W,_,,,,,,,,,,,,,,,---!------------...!.,.-.9.N.R.S.W.Y.[.q.u................// / / //!/#/%/7/=/B/I/\/c/t/y/z/{/////////////00 0000J0S0U0b0c0i0k0m00000000000001&1'1/11131;1J1K1R1k1t1v1x12 -.DE*nop s   hjknp HIsuvxy{bdehj  dfgkmo/124689"$%')+qr01FHIKMOjlmoqstanpqstvw$&'*,.DFGJLN*HJKMOQIKLNPR   oqruwy:<=@BD`b2458:<ixz{}     F G k m n q s u !N!P!Q!S!U!W!!!!!!!!!!!;"=">"@"B"D"E""""""""L#N#O#Q#S#U#########$$$$ $ $!$#$$$$$$$$$J%L%M%O%Q%S%%%%%%%%%%%I&J&&&&&&& ' 'g'i'j'l'm'o'x'z'((((((H(I(((((((((((((((l)n)o)r)t)v)***** ***f*h*i*m*o*q*|*~********e+w+y+z+|+~++++++++5,7,8,:,<,>,,,,,,,,,,,,,,,,----------.......Y.[.\.^._.a.k.p.......//#/%/&/(/*/,/Z/[/\/b/////////000000k0m0n0p0r0t000000000001131416181:1@1B1v1x1y1|1~1{22- RXw&[fQwU}"A,<P [tcw9~6X,R0Sdz-E=k ^ v D!X!!!."T""#?#c#### $$$;%T%%%&&L'{' (+(((((`)))*[****g++++(,?,,,,,---.N.b.../-/// 0)0U00001;1k1~12z{q q (,(,4,4,~1~12cCTpf U t8~z, X=x \>s"J F%DTF89(l&$,vΒhX,Ds6m-~'J{F0||2dm7R,;~'J{ v=A?C^#*GDs>CQVVQT~P@%UDs"9RWDs}iDskDsk||caq&xqq4wsJ8"~h ^`hH.h ^`hH.h pLp^p`LhH.h @ @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PLP^P`LhH.h ^`hH.h ^`hH.h pL^p`LhH.h @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PL^P`LhH.h .^.`o(hH.^`. L^ `L. ^ `.n^n`.>L^>`L.^`.^`.L^`L.)?^)`?>*o(. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.h ^`hH.^`.pL^p`L.@ ^@ `.^`.L^`L.^`.^`.PL^P`L.^`CJOJQJ^JaJ ^`OJQJ^Jo ^ `CJOJQJ^JaJ w ^w `OJQJ^J G^G`OJQJ^Jo^`CJOJQJ^JaJ ^`OJQJ^J ^`OJQJ^Jo^`CJOJQJ^JaJ)?^)`?>*o(. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.h .^.`hH.^`. L^ `L. ^ `.n^n`.>L^>`L.^`.^`.L^`L.^`CJPJ^JsHtH.o^o`CJOJQJ^JsHtH-pL^p`L.@ ^@ `.^`.L^`L.^`.^`.PL^P`L.h ^`hH.h ^`hH.h  L^ `LhH.h f ^f `hH.h 6^6`hH.h L^`LhH.h ^`hH.h ^`hH.h vL^v`LhH. ^`hH. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.h .^.`hH.^`.pL^p`L.@ ^@ `.^`.L^`L.^`.^`.PL^P`L.h ^`hH.^`.pL^p`L.@ ^@ `.^`.L^`L.^`.^`.PL^P`L.^`.^`.pL^p`L.@ ^@ `.^`.L^`L.^`.^`.PL^P`L.h^h`CJPJ^JaJsHtH.^`CJOJQJ^JaJsHtH-L^`L. ^ `. ^ `.xL^x`L.H^H`.^`.L^`L.h I^I`hH.^`. L^ `L.\ ^\ `.,^,`.L^`L.^`.^`.lL^l`L. ^`hH. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH. ^`hH. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.h^h`56CJPJ^JaJsHtH.^`.pL^p`L.@ ^@ `.^`.L^`L.^`.^`.PL^P`L.^`.^`.pL^p`L.@ ^@ `.^`.L^`L.^`.^`.PL^P`L. ^`hH. ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH. ^`hH. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH. ^`hH. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH. ^`hH. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH. ^`hH. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.h ^`hH.^`.pL^p`L.@ ^@ `.^`.L^`L.^`.^`.PL^P`L.^`.^`.pL^p`L.@ ^@ `.^`.L^`L.^`.^`.PL^P`L.)?^)`?>*o(. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH. ^`hH. ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.h ^`hH.h ^`hH.h pL^p`LhH.h @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PL^P`LhH.$&$,cCwsTVQ=k@%U}i"9RWGhX,f 8"~kF0caq9(>CQx7caq9(>CQx 7(?C v=qq>s"~z, 2 F%U 6m-,;ЩgШgvgФgФg                 :b                 :b                                                                                                                                      :b                 x]ZK2:\;=UA* :3N,F<R{i6E{w L, M>j^8  eGK%o;:,Yp|].  h w= Pn A  'E Q  ' ;Z7 U P In b `"WY]NB?^FDh_&HPz#qzf46gIp}CfeTg7 }i(:btM1v A7p6M'n/r<k[ZZj&oq~&am&*n&o'65''zN(m(O2[)u)-_)h)l+A*b`*4 *H^*W +4+u3+FF,lR-7x-V.R/vL1xeR1(h1ev2]3w2c2B2*k2w2,i3"313@3 h3R'<4N54y<5 m?5fO5+;5e6.~6J6N=7R|778t59W?9s9i:R;>";j2;Z;w+<@[E<Q= '= XL=MO=sB >$;>>f>0>BT@Ak@#|@4@ lZAz(A AYBm9BI]B .C'C/C;LCECyAEgEFWG9H0IDIwI/Ik9MJ=Jg+JnJ J"bKdK"KBI8LALBL/LyLL?LwUM{MkMBM?xOWcO>FOKPgoQQlm4RMRU9SUS;S(SryTTsUT%VbXmVNBVWyWOW`XqXqvq-r/rpr=r72@shs;~s4Ust^tv t27u-XJu;Mv/DMvqNv<~UvPlv0vipv*xty_yTirys]yy9z{z:{E|fE}Z}-,}U~:~#~68_GAX: >9JQu86.b;L}\_5T Vv    6 9 wX %M#Qb-z"WZaa\oE1$Wvkr^f oi!\"}#$-$S$i$p;&E9(8*@Z*+|+I,Ma,|r,o-6-J:./U0Ar01gO2*`3I4f5m56u378f$89=s9:;Ug;x; f?O@Bg&BD "E8GeG xIJRkK[LL3L9L M8qMfNOBOP:&P8QTQMRIS>U>OVZV[X;YoZuc\q]-^"_`_d_pa@`awAbNb& c)cFc+e3z K#.C^ v lS[tj!58RSwXey|kFT_E*=O*$Y&u/YLX_`S:OOu@4OVc7|}}iy hBn2(T}mw'o<8(K8+4;X9iQV *  x!??;B1wkZ Kg57b~z}y^dG,punLgB>KdaF $BkKi22@u1u1(Iu1u1Op** RRRRR2``@``8@` `&`(`:`|Unknown G.[x Times New Roman5Symbol3. .[x Arial7..{$ Calibri9. . Segoe UI?= .Cx Courier NeweAndale Sans UITimes New Roman5. .[`)Tahoma;WingdingsA$BCambria Math"qhegGw*[*[!nT24f2f2 2qHP ? f?2! xx " !2Sergey User Windows     +  ) ,  3 *       (   Oh+'0  < H T `lt| 2SergeyNormalUser Windows119Microsoft Office Word@vT@/xia@ZQ@|T&5b*՜.+,0 hp  Home[f2  2    !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrsuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXY[\]^_`acdefghinorRoot Entry Fk5=5bq@Data tR 1Table-WordDocument 4SummaryInformation(ZDocumentSummaryInformation8bMsoDataStoreP=5b-=5bK0XREGEZEQ==2P=5b-=5bItem  2PropertiesUCompObj y   F' Microsoft Office Word 97-2003 MSWordDocWord.Document.89q